The Centers for Disease Control and Prevention (CDC) updated their COVID-19 isolation guidance, revising the minimum 5-day isolation period plus added precautions for those that are infected with the virus.

As we navigate through another season marked by the co-circulation of multiple respiratory viruses, it's crucial to recognize the progress we've made and the resources at our disposal. Unfortunately, only 19% of eligible Americans have received the updated COVID-19 vaccine and less than 50% received this year’s flu vaccine. With elevated activity for COVID-19, flu, and RSV, it's not too late to benefit from vaccinations and available treatments. The Swiss cheese model of defense remains a reliable strategy for reducing infection risks, and the government's expanded Home Test to Treat Initiative offers a valuable resource for managing COVID-19 and flu. As we adapt to this new normal, it's imperative to utilize these tools and strategies to safeguard our health and that of our loved ones, especially the most vulnerable among us. The fight against these respiratory viruses is a collective effort, and by staying informed and proactive, we can navigate this season more effectively. 

As we approach this year's respiratory season it's important to recognize the importance of vaccination and how vaccines help reduce the risk of serious illness, hospitalization and death. 

The virus responsible for COVID-19 (SARS-CoV-2) undergoes constant genetic changes as it mutates over time. This is normal and what most viruses do. Because of this, we do anticipate the continual emergence of new SARS-CoV-2 variants. While some of these variants might appear and then fade away - think of the Delta variant which became the dominate variant in the late summer and fall of 2021 in the U.S. - others could increase, potentially taking the place of older variants.

Belfer Fellow Syra Madad Commends Department of Defense for Inaugural 2023 Biodefense Posture Review.

Syra Madad issued a statement on two Biden Administration biodefense plans: National Biodefense Strategy and Implementation Planand the National Security Memorandum on Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Security.

Ask yourself, what would you say to someone if they told you in just over two years, a virus too small to see with the naked eye but brutal enough to kill a population the size of Delaware would sweep through the nation?

As leaders in one of the largest healthcare systems in the United States, we would say: this would be a travesty of epic proportions.

Throughout this spring, Belfer Fellow Dr. Syra Madad developed and hosted a Women in STEM event series to highlight women leaders in Science, Technology, Engineering, and Mathematics (STEM). The aim of the series was to recognize the many accomplishments and contributions by women in STEM fields while educating and empowering young women, providing valuable advice, and sharing pearls of wisdom. This six-event series featured guest speakers that included America's Top Young Scientist Gitanjali Rao, former White House Senior Advisor Valerie Jarrett, leading figure in the U.S. space program Lori Garver and Spacecraft Operations Engineer Nagin Cox, Tiktok-renowned epidemiologist Dr. Katrine Wallace, and many more.

As more states remove mask mandates and schools decide to lift masking policies, it can be a confusing time for children. There may be feelings of fear and anxiety. Whether its elementary, middle school or high school aged kids, now is the time to begin talking about the transition, regardless of whether your child will continue to wear a mask or decide not to.

Belfer Center Fellow Syra Madad, an internationally  recognized leader and epidemiologist in public health and special pathogens preparedness and response, has been named to the National Science Advisory Board for Biosecurity (NSABB). The NSABB is a federal advisory committee that addresses issues related to biosecurity and dual use research at the request of the U.S. government. The board has 25 voting members selected for their expertise in areas that range from biosecurity, molecular biology, and animal and plant health to infectious diseases, biodefense, law enforcement, scientific publishing, and other related fields.